Cappelleri Joseph C, Bushmakin Andrew G, Baker Christine L, Merikle Elizabeth, Olufade Abayomi O, Gilbert David G
Pfizer Inc, Global Research and Development, Groton, CT 06340, USA.
Curr Med Res Opin. 2005 May;21(5):749-60. doi: 10.1185/030079905X43712.
The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric properties of the MNWS.
Data came from three Phase II clinical trials on varenicline, developed for smoking cessation, in a sample of smokers. Exploratory factor analysis was used to examine the structure of the MNWS in the first completed study (n = 626) over various time periods. The postulated factor structure was then tested in a set of confirmatory analyses conducted on two subsequent studies (n = 627, n = 312). The proposed structure was further evaluated through construct validity and reliability analyses.
The nine items of the MNWS included the following: urge to smoke (craving); depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; increased appetite; difficulty going to sleep; and difficulty staying asleep. Each item was rated by a subject on an ordinal scale from 0 (not at all) to 4 (extreme).
Scree plots and rotated factor patterns from the exploratory factor analyses revealed two multi-item domains--Negative Affect with four items and Insomnia with two items--and three individual items (Craving, Restlessness, Increased Appetite). Confirmatory factor analyses supported the structure with fit indexes exceeding 0.90. The multidimensional framework of the MNWS correlated as expected with health status, depicted an expected course of withdrawal symptoms over time, predicted the sensitivity of withdrawal symptoms on subsequent cessation, and produced internal reliability estimates above 0.70.
Evidence is obtained to support the validity and reliability of the multidimensional structure of the nine-item MNWS. The data suggest that the MNWS has individual constructs on Negative Affect (depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating), Insomnia (difficulty going to sleep; difficulty staying asleep), Craving, Restlessness, and Increased Appetite. As such, analyzing each construct separately would strengthen the analysis of the popular MNWS.
正在考虑的明尼苏达尼古丁戒断量表(MNWS)版本包含九个项目。尚未发表对该版本的心理测量分析。本研究的目的是进行因子分析并进一步评估MNWS的心理测量特性。
数据来自三项关于伐尼克兰的II期临床试验,该药物是为戒烟而研发的,样本为吸烟者。在第一项完成的研究(n = 626)中,在不同时间段使用探索性因子分析来检验MNWS的结构。然后在对随后两项研究(n = 627,n = 312)进行的一组验证性分析中检验假定的因子结构。通过结构效度和信度分析进一步评估所提出的结构。
MNWS的九个项目包括以下内容:吸烟冲动(渴望);情绪低落;易怒、沮丧或愤怒;焦虑;注意力难以集中;坐立不安;食欲增加;入睡困难;以及睡眠维持困难。每个项目由受试者按从0(完全没有)到4(极其严重)的顺序量表进行评分。
探索性因子分析的碎石图和旋转因子模式揭示了两个多项目领域——包含四个项目的消极情绪和包含两个项目的失眠——以及三个单个项目(渴望、坐立不安、食欲增加)。验证性因子分析支持该结构,拟合指数超过0.90。MNWS的多维框架与健康状况的相关性符合预期,描绘了戒断症状随时间的预期病程,预测了戒断症状对后续戒烟的敏感性,并产生了高于0.70的内部信度估计值。
获得了支持九项目MNWS多维结构的效度和信度的证据。数据表明,MNWS在消极情绪(情绪低落;易怒、沮丧或愤怒;焦虑;注意力难以集中)、失眠(入睡困难;睡眠维持困难)、渴望、坐立不安和食欲增加方面具有单独的结构。因此,分别分析每个结构将加强对广受欢迎的MNWS的分析。